Generalized morphoea secondary to porphyria cutanea tarda.
We report a patient with generalized morphoea secondary to porphyria cutanea tarda, who responded to treatment with cyclosporin. The differences between the sclerodermatous skin changes seen in porphyria cutanea tarda and generalized morphoea are discussed.
Stevens
H P
HP
Department of Dermatology, Royal Free Hospital and School of Medicine, London, U.K.
Ostlere
L S
LS
Black
C M
CM
Rustin
M H
MH
D016572:Cyclosporine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D017119:Porphyria Cutanea Tarda / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D012594:Scleroderma, Localized / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D012867:Skin / Q000473:pathology
D016572:Cyclosporine